Article
20 Oct 2026
GLOBE Most Favored Nations Drug Pricing Model For Medicare Part B Drugs Finalized And Scaled Down By CMS
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
18 Aug 2026
Deadline Approaching: OIG Seeks Input On Anti-Kickback Safe Harbors For Clinical Trial Participant Remuneration
Article
05 Aug 2026
340B Drug Rebate Pilot Program Revised By HRSA
Article
05 Jun 2026
Supreme Court Declines To Review $220 Million Drug Pricing Judgment Against Eli Lilly
Article
25 Mar 2026
Ninth Circuit Enables 340B False Claims Act Enforcement
Article
06 Jan 2026
Health Headlines: December 2025
Article
29 Dec 2025
CMS Releases MFN Drug Pricing Models For Medicare Parts B And D And Medicaid Amid Trump Administration's Push For Direct-to-Consumer Strategy